AIM ImmunoTech Inc. (AIMI) is a biotechnology company listed on US.
Latest reported AIMI revenue for 2024-12-31 was $170.0K. Net income was -$17.3M. Revenue was down 15.8% from 2023-12-31 to 2024-12-31. AIMI currently screens at market cap $878.9K.
Use this AIMI page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AIMI quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AIMI SEC filings page. Lician reads the product cache first so this HTML stays unique to AIM ImmunoTech Inc. even when a live quote feed is slow.
Latest cached year on this hub. Full AIMI income, balance, and cash tables.